Exocrine Pancreas Carcinoma

Observed

← altered in cohorts of

CXXC1

114 / 185 cases (62 %) · ssm · TCGA-PAAD

—

Observed

← altered in cohorts of

MAPK4

114 / 185 cases (62 %) · ssm · TCGA-PAAD

—

Observed

← altered in cohorts of

MBD1

114 / 185 cases (62 %) · ssm · TCGA-PAAD

—

Observed

← altered in cohorts of

ME2

114 / 185 cases (62 %) · ssm · TCGA-PAAD

—

Observed

← altered in cohorts of

SKA1

114 / 185 cases (62 %) · ssm · TCGA-PAAD

—

Observed

← altered in cohorts of

C18orf54

113 / 185 cases (61 %) · ssm · TCGA-PAAD

—

Observed

← altered in cohorts of

DCC

113 / 185 cases (61 %) · ssm · TCGA-PAAD

—

Observed

← altered in cohorts of

MBD2

113 / 185 cases (61 %) · ssm · TCGA-PAAD

—

Observed

← altered in cohorts of

MEX3C

113 / 185 cases (61 %) · ssm · TCGA-PAAD

—

Observed

← altered in cohorts of

MRO

113 / 185 cases (61 %) · ssm · TCGA-PAAD

—

Observed

← altered in cohorts of

MYO5B

113 / 185 cases (61 %) · ssm · TCGA-PAAD

—

Observed

← altered in cohorts of

POLI

113 / 185 cases (61 %) · ssm · TCGA-PAAD

—

Observed

← altered in cohorts of

STARD6

113 / 185 cases (61 %) · ssm · TCGA-PAAD

—

Observed

← altered in cohorts of

TCF4

113 / 185 cases (61 %) · ssm · TCGA-PAAD

—

Observed

Exocrine Pancreas Carcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived162 of 162show fewer
→ investigated in trials for	Gemcitabinesmall molecule 175 trials (58 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	175	Observed	clinicaltrials	graph →
→ investigated in trials for	Nab-paclitaxel 102 trials (45 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	102	Observed	clinicaltrials	graph →
→ investigated in trials for	Fluorouracilsmall molecule 68 trials (29 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	68	Observed	clinicaltrials	graph →
→ investigated in trials for	Oxaliplatinsmall molecule 54 trials (21 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	54	Observed	clinicaltrials	graph →
→ investigated in trials for	Irinotecansmall molecule 51 trials (25 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	51	Observed	clinicaltrials	graph →
→ investigated in trials for	Leucovorinsmall molecule 51 trials (25 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	51	Observed	clinicaltrials	graph →
→ investigated in trials for	Pembrolizumabmonoclonal antibody 34 trials (17 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	34	Observed	clinicaltrials	graph →
→ investigated in trials for	Capecitabinesmall molecule 21 trials (6 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	21	Observed	clinicaltrials	graph →
→ investigated in trials for	Cisplatinsmall molecule 20 trials (11 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	20	Observed	clinicaltrials	graph →
→ investigated in trials for	Bevacizumabmonoclonal antibody 17 trials (6 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	17	Observed	clinicaltrials	graph →
→ investigated in trials for	Paclitaxelsmall molecule 16 trials (6 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	16	Observed	clinicaltrials	graph →
→ investigated in trials for	Cetuximabmonoclonal antibody 14 trials (9 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	14	Observed	clinicaltrials	graph →
→ investigated in trials for	Durvalumabmonoclonal antibody 13 trials (5 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	13	Observed	clinicaltrials	graph →
→ investigated in trials for	Nivolumabmonoclonal antibody 12 trials (5 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	12	Observed	clinicaltrials	graph →
→ investigated in trials for	Cyclophosphamidesmall molecule 10 trials (1 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	10	Observed	clinicaltrials	graph →
→ investigated in trials for	Olaparibsmall molecule 10 trials (6 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	10	Observed	clinicaltrials	graph →
→ investigated in trials for	Chemotherapy 9 trials (2 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	9	Observed	clinicaltrials	graph →
→ investigated in trials for	Carboplatinsmall molecule 8 trials (4 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	8	Observed	clinicaltrials	graph →
→ investigated in trials for	Docetaxelsmall molecule 8 trials (5 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	8	Observed	clinicaltrials	graph →
→ investigated in trials for	Atezolizumabmonoclonal antibody 7 trials (3 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	7	Observed	clinicaltrials	graph →
→ investigated in trials for	Fludarabinesmall molecule 7 trials (1 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	7	Observed	clinicaltrials	graph →
→ investigated in trials for	Dasatinibsmall molecule 6 trials (2 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	6	Observed	clinicaltrials	graph →
→ investigated in trials for	Erlotinibsmall molecule 6 trials (1 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	6	Observed	clinicaltrials	graph →
→ investigated in trials for	Erlotinib Hydrochloridesmall molecule 6 trials (2 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	6	Observed	clinicaltrials	graph →
→ investigated in trials for	Metforminsmall molecule 6 trials (1 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	6	Observed	clinicaltrials	graph →
→ investigated in trials for	Tislelizumabmonoclonal antibody 6 trials (4 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	6	Observed	clinicaltrials	graph →
→ investigated in trials for	Vismodegibsmall molecule 6 trials (2 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	6	Observed	clinicaltrials	graph →
→ investigated in trials for	FOLFIRI Regimen 5 trials (2 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Ipilimumabmonoclonal antibody 5 trials (2 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Pemetrexedsmall molecule 5 trials (4 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Aldesleukinother 4 trials (0 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Binimetinibsmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Cobimetinibsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	4	Observed	clinicaltrials	graph →
→ investigated in trials for	FOLFOX Regimen 4 trials (2 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Ganitumabmonoclonal antibody 4 trials (0 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Palbociclibsmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Ruxolitinibsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Selumetinibsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Sunitinibsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Trametinibsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Dostarlimabmonoclonal antibody 3 trials (1 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Doxorubicinsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Hydroxychloroquinesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Lenvatinibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Niraparibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Panitumumabmonoclonal antibody 3 trials (3 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Sirolimussmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Sonidegibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Tretinoinsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Veliparibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Vorinostatsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Abemaciclibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Adavosertibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Afatinibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Akt Inhibitor MK2206 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Alvocidibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Bortezomibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Cabozantinibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Cediranibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Ceritinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Copanlisibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Dabrafenibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Decitabinesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Elimusertibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Everolimussmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Immunomodulatory Oligonucleotide 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Lenalidomidesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Neratinibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Pertuzumabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Ramucirumabmonoclonal antibody 2 trials (2 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Regorafenibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Retifanlimabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Rucaparibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Sintilimabmonoclonal antibody 2 trials (2 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Sorafenibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Sorafenib Tosylatesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Temsirolimussmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Trastuzumab Emtansineadc 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Tremelimumabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Zolbetuximabmonoclonal antibody 2 trials (2 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Abirateronesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Adagrasibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Adebrelimabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Alisertibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Anti-PD1 Monoclonal Antibody 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Arsenic Trioxidesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Avelumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Azacitidinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Bendamustinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Bicalutamidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Birabresibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Buparlisibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Cabazitaxelsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Calaspargase Pegolother 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Capivasertibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	CAPOX Regimen 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Carboplatin/Paclitaxel Regimen 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Carboplatin/Pemetrexed Regimen 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Carmustinesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Celecoxibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Cemiplimabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Conatumumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Crizotinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Daratumumabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Darolutamidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Dinaciclibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Dovitinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Enasidenibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Encorafenibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Enfortumab Vedotinadc 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Entrectinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Enzalutamidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Erdafitinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Eribulinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Fexagratinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Futibatinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Ganetespibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Guadecitabinesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Ibrutinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Idelalisibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Imatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Imiquimodsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Immunotherapy 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Ipatasertibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Ipilimumab/Nivolumab Regimen 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Ivosidenibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	L19IL2 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Larotrectinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Levoleucovorinsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Lomustinesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Lorlatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Luminespibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Lurbinectedinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Melphalansmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Osimertinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Panobinostatsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Pegfilgrastimother 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Ponatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Porfimer 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Romidepsinother 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Samotolisibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Sapanisertibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Selinexorsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Serplulimabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Setidegrasibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Talazoparibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Tanespimycinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Taselisibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Tazemetostatsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Tegafursmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Therapeutic Tumor Infiltrating Lymphocytes 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Tipifarnibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Tivozanibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Tofacitinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Topotecansmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Toripalimabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Trastuzumabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Valproic Acidsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Vemurafenibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Venetoclaxsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Verteporfinsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Zoledronic Acidsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →

Exocrine Pancreas Carcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived162 of 162show fewer

→ investigated in trials for

Gemcitabinesmall molecule

175 trials (58 active) · roll-up of the cancer and its descendants

—

175

Observed

→ investigated in trials for

Nab-paclitaxel

102 trials (45 active) · roll-up of the cancer and its descendants

—

102

Observed

→ investigated in trials for

Fluorouracilsmall molecule

68 trials (29 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Oxaliplatinsmall molecule

54 trials (21 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Irinotecansmall molecule

51 trials (25 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Leucovorinsmall molecule

51 trials (25 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Pembrolizumabmonoclonal antibody

34 trials (17 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Capecitabinesmall molecule

21 trials (6 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cisplatinsmall molecule

20 trials (11 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Bevacizumabmonoclonal antibody

17 trials (6 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Paclitaxelsmall molecule

16 trials (6 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cetuximabmonoclonal antibody

14 trials (9 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Durvalumabmonoclonal antibody

13 trials (5 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Nivolumabmonoclonal antibody

12 trials (5 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cyclophosphamidesmall molecule

10 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Olaparibsmall molecule

10 trials (6 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Chemotherapy

9 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Carboplatinsmall molecule

8 trials (4 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Docetaxelsmall molecule

8 trials (5 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Atezolizumabmonoclonal antibody

7 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Fludarabinesmall molecule

7 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Dasatinibsmall molecule

6 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Erlotinibsmall molecule

6 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Erlotinib Hydrochloridesmall molecule

6 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Metforminsmall molecule

6 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Tislelizumabmonoclonal antibody

6 trials (4 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Vismodegibsmall molecule

6 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

FOLFIRI Regimen

5 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ipilimumabmonoclonal antibody

5 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Pemetrexedsmall molecule

5 trials (4 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Aldesleukinother

4 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Binimetinibsmall molecule

4 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cobimetinibsmall molecule

4 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

FOLFOX Regimen

4 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ganitumabmonoclonal antibody

4 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Palbociclibsmall molecule

4 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ruxolitinibsmall molecule

4 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Selumetinibsmall molecule

4 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Sunitinibsmall molecule

4 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Trametinibsmall molecule

4 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Dostarlimabmonoclonal antibody

3 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Doxorubicinsmall molecule

3 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Hydroxychloroquinesmall molecule

3 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Lenvatinibsmall molecule

3 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Niraparibsmall molecule

3 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Panitumumabmonoclonal antibody

3 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Sirolimussmall molecule

3 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Sonidegibsmall molecule

3 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Tretinoinsmall molecule

3 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Veliparibsmall molecule

3 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Vorinostatsmall molecule

3 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Abemaciclibsmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Adavosertibsmall molecule

2 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Afatinibsmall molecule

2 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Akt Inhibitor MK2206

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Alvocidibsmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Bortezomibsmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cabozantinibsmall molecule

2 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cediranibsmall molecule

2 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ceritinibsmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Copanlisibsmall molecule

2 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Dabrafenibsmall molecule

2 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Decitabinesmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Elimusertibsmall molecule

2 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Everolimussmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

Immunomodulatory Oligonucleotide

→ investigated in trials for

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Lenalidomidesmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Neratinibsmall molecule

2 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Pertuzumabmonoclonal antibody

2 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ramucirumabmonoclonal antibody

2 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Regorafenibsmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Retifanlimabmonoclonal antibody

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Rucaparibsmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Sintilimabmonoclonal antibody

2 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Sorafenibsmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Sorafenib Tosylatesmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Temsirolimussmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Trastuzumab Emtansineadc

2 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Tremelimumabmonoclonal antibody

2 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Zolbetuximabmonoclonal antibody

2 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Abirateronesmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Adagrasibsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Adebrelimabmonoclonal antibody

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Alisertibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

Anti-PD1 Monoclonal Antibody

→ investigated in trials for

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Arsenic Trioxidesmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Avelumabmonoclonal antibody

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Azacitidinesmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Bendamustinesmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Bicalutamidesmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Birabresibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Buparlisibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cabazitaxelsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Calaspargase Pegolother

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Capivasertibsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

CAPOX Regimen

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

Carboplatin/Paclitaxel Regimen

→ investigated in trials for

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

Carboplatin/Pemetrexed Regimen

→ investigated in trials for

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Carmustinesmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Celecoxibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cemiplimabmonoclonal antibody

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Conatumumabmonoclonal antibody

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Crizotinibsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Daratumumabmonoclonal antibody

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Darolutamidesmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Dinaciclibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Dovitinibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Enasidenibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Encorafenibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Enfortumab Vedotinadc

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Entrectinibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Enzalutamidesmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Erdafitinibsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Eribulinsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Fexagratinibsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Futibatinibsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ganetespibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Guadecitabinesmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ibrutinibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Idelalisibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Imatinibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Imiquimodsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Immunotherapy

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ipatasertibsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

Ipilimumab/Nivolumab Regimen

→ investigated in trials for

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ivosidenibsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

L19IL2

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Larotrectinibsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Levoleucovorinsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Lomustinesmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Lorlatinibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Luminespibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Lurbinectedinsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Melphalansmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Osimertinibsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Panobinostatsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Pegfilgrastimother

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ponatinibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Porfimer

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Romidepsinother

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Samotolisibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Sapanisertibsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Selinexorsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Serplulimabmonoclonal antibody

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Setidegrasibsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Talazoparibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Tanespimycinsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Taselisibsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Tazemetostatsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Tegafursmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

Therapeutic Tumor Infiltrating Lymphocytes

→ investigated in trials for

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Tipifarnibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Tivozanibsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Tofacitinibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Topotecansmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Toripalimabmonoclonal antibody

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Trastuzumabmonoclonal antibody

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Valproic Acidsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Vemurafenibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Venetoclaxsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Verteporfinsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Zoledronic Acidsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

Exocrine Pancreas Carcinoma studied in …STUDIED_INderived10 of 919show all (up to 200)
→ studied in	NCT02465060Phase 2 · active not recruiting Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active)	—	—	Exocrine Pancreas Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04548752Phase 2 · active not recruiting Testing the Addition of Pembrolizumab, an Immunotherapy Cancer Drug to Olaparib Alone as Therapy for Patients With Pancreatic Cancer That Has Spread With Inherited BRCA Mutations · condition mapped CURATED_BROADER · 919 trials mapped (414 active)	—	—	Pancreatic Adenocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04605913Phase 1/Phase 2 · active not recruiting Nab-Paclitaxel + Cisplatin + Gemcitabine + TTF in pt. w/ Metastatic PAC · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active)	—	—	Pancreatic Adenocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05877599Phase 1 · recruiting A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active)	—	—	Pancreatic Adenocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06608927Phase 3 · active not recruiting Study of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma · condition mapped CURATED_BROADER · 919 trials mapped (414 active)	—	—	Pancreatic Ductal Adenocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07845617recruiting Hepatic Artery Infusion Pump Chemotherapy for Liver Metastases From Resected Pancreatic and Duodenal Adenocarcinoma · condition mapped ALIAS · 919 trials mapped (414 active)	—	—	Pancreatic Adenocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05482893Phase 1/Phase 2 · recruiting Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study) · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active)	—	—	Pancreatic Ductal Adenocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06388967recruiting Pancreatic Cancer Detection Consortium · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active)	—	—	Pancreatic Adenocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07621718Phase 3 · recruiting Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 ) · condition mapped ALIAS · 919 trials mapped (414 active)	—	—	Pancreatic Ductal Adenocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02498613Phase 2 · active not recruiting A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors · condition mapped CURATED_BROADER · 919 trials mapped (414 active)	—	—	Pancreatic Adenocarcinoma	1	Observed	clinicaltrials	graph →

Exocrine Pancreas Carcinoma studied in …STUDIED_INderived10 of 919show all (up to 200)

→ studied in

NCT02465060Phase 2 · active not recruiting

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active)

—

Observed

→ studied in

NCT04548752Phase 2 · active not recruiting

Testing the Addition of Pembrolizumab, an Immunotherapy Cancer Drug to Olaparib Alone as Therapy for Patients With Pancreatic Cancer That Has Spread With Inherited BRCA Mutations · condition mapped CURATED_BROADER · 919 trials mapped (414 active)

—

Observed

→ studied in

NCT04605913Phase 1/Phase 2 · active not recruiting

Nab-Paclitaxel + Cisplatin + Gemcitabine + TTF in pt. w/ Metastatic PAC · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active)

—

Observed

→ studied in

NCT05877599Phase 1 · recruiting

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active)

—

Observed

Pancreatic Ductal Adenocarcinoma

→ studied in

NCT06608927Phase 3 · active not recruiting

Study of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma · condition mapped CURATED_BROADER · 919 trials mapped (414 active)

—

Observed

→ studied in

NCT07845617recruiting

Hepatic Artery Infusion Pump Chemotherapy for Liver Metastases From Resected Pancreatic and Duodenal Adenocarcinoma · condition mapped ALIAS · 919 trials mapped (414 active)

—

Observed

Pancreatic Ductal Adenocarcinoma

→ studied in

NCT05482893Phase 1/Phase 2 · recruiting

Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study) · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active)

—

Observed

→ studied in

NCT06388967recruiting

Pancreatic Cancer Detection Consortium · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active)

—

Observed

Pancreatic Ductal Adenocarcinoma

→ studied in

NCT07621718Phase 3 · recruiting

Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 ) · condition mapped ALIAS · 919 trials mapped (414 active)

—

Observed

→ studied in

NCT02498613Phase 2 · active not recruiting

A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors · condition mapped CURATED_BROADER · 919 trials mapped (414 active)

—

Observed